Global Wearable Medical Device Market Poised for Significant Growth, Expected to Reach USD 84.8 Billion by 2034 at a 8.2% of CAGR

Global Wearable Medical Device Market
Global Wearable Medical Device Market

The global wearable medical device industry is set for substantial expansion, with projected sales reaching USD 38.5 billion in 2024. The market is anticipated to experience robust growth over the assessment period from 2024 to 2034, with a compound annual growth rate (CAGR) of 8.2%, leading to an estimated market size of USD 84.8 billion by the end of 2034.

Wearable medical devices, which encompass a range of technologies designed for continuous health monitoring and management, are increasingly becoming integral to modern healthcare. These devices offer users the ability to track vital signs, manage chronic conditions, and improve overall health outcomes with real-time data and personalized insights.

Wearable medical devices are emerging as a pivotal solution to address these challenges, offering continuous monitoring and real-time data collection. This trend is further accelerated by the active encouragement of routine diagnosis by regional and national healthcare agencies through awareness programs and various campaigns. These initiatives are fostering heightened awareness among the masses regarding the benefits of wearable medical devices for monitoring and diagnosing vital signs.

Key Takeaways from the Wearable Medical Device Market Report

  • The wearable medical device market achieved a market size of US$ 36,604.3 million in 2023. During the historical period, the market registered a CAGR of 7%.
  • By product, the wearable therapeutic medical device segment is estimated to acquire a value share of 55% in 2024.
  • Based on the application, the home healthcare segment is anticipated to obtain a market share of 63% in 2024.
  • The wearable medical device industry in the United States is expected to expand at a CAGR of 5% through 2034.
  • The wearable medical device market in France is projected to register a CAGR of 8% from 2024 to 2034.
  • The wearable medical device market in India is estimated to record a staggering CAGR of 40% over the forecast period.
  • The market in Singapore is projected to grow at a CAGR of 10% through 2034.

“Continuous advancements and release of upgraded wearable medical devices by leading players are expected to be a go-to-market strategy of leading players. Additionally, players are expected to explore the potential of wearable medical devices in various new segments,” says Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.)

Competitive Landscape in the Wearable Medical Device Market

Market players are developing advanced wearables and exploring new application cases for wearable medical devices, which is contributing to market growth. The industry participants are acquiring firms with complementary technologies and collaborating with other healthcare institutions, technology providers, and pharmaceutical firms to expand their distribution channels, leverage expertise, and develop integrated solutions.

Players are further emphasizing privacy and data security and prioritizing user-friendly designs to boost user adoption and compliance. Industry participants are getting involved in targeted marketing campaigns toward certain healthcare professionals and patient segments to elevate brand recognition and drive device adoption.

Recent Developments in the Wearable Medical Device Market

In July 2023, Dexcom, a developer of constant glucose monitors, revealed that it is making a Type 2 diabetes monitor for patients who don’t require insulin. The company also offers a cash-pay choice for patients not secured by health insurers and Medicare.

  • In July 2023, Samsung announced that it is gearing up to launch the ‘Galaxy Ring’ equipped with smart health features in 2024. For the success of its recent wearable endeavor, the Korean tech giant is collaborating with international as well as domestic component manufacturers.

Manufacturers of the Wearable Medical Device Market

  • Medtronic plc
  • Siemens AG
  • Fitbit Inc.
  • Bayer AG
  • Panasonic Corporation
  • Animas Corporation – Johnson and Johnson
  • Smiths Medical – A Smiths Group Company
  • Koninklijke Philips N.V.
  • Owlet Baby Care
  • OMRON Corporation
  • Hoffmann-La Roche Ltd
  • Rest Devices Inc.
  • Others

A Full Report – Overview

Wearable Medical Device Market Segmentation

By Product:

  • Wearable Monitoring and Diagnostic Devices
  • Fetal and Obstetric Devices
    • Wearable Foetal Monitors
    • Infant Motion Sensing Monitors
  • Continuous Glucose Monitoring Devices
  • Cardiac Monitoring Devices
    • Wearable Heart Rate Monitors
    • Wearable Pulse Oximeters
    • Wearable Blood Pressure Monitors
  • Wearable Therapeutic Medical Device
  • Hearing Aid
  • Insulin Pump
  • Respiratory Therapy Devices
  • Health and Fitness Devices

By Application:

By Distribution Channel:

  • Hospital Pharmacies
  • Clinics
  • Online Channels
  • Hypermarkets

By Region:

  • North America
  • Europe
  • Asia Pacific
  • Middle East and Africa
  • Latin America

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, Stevie Award – recipient market research organization, and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments based on Source, Application, Sales Channel, and End Use over the next 10-years.

Contact Us:          

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Rapeseed Protein Industry Expansion: Forecasted Market Value of USD 10.6 Billion by 2034, Growing at a 3.1% CAGR

The global rapeseed protein market is projected to reach a value of USD 7.8 billion in 2024, with expectations to expand to USD 10.6 billion by 2034. The market is anticipated to grow at a CAGR of 3.1% throughout the forecast period.

Sales of rapeseed protein isolates continue to be robust due to their high protein content and additional benefits. This segment represented 42% of the market revenue in 2023 and is projected to experience steady growth through 2034.

The rapeseed protein industry is poised for growth, driven by the increasing global demand for plant-based proteins.

Consumers worldwide, particularly vegans, are increasingly gravitating towards plant-based products, which is driving up the demand for plant-based proteins like rapeseed protein.

Rapeseed protein is prominently featured in a variety of food products, including plant-based meat substitutes, shakes, and baked goods. This widespread use in the food and beverage industry is significantly contributing to market growth.

Additionally, rapeseed protein’s popularity is rising in the animal feed sector due to its excellent amino acid profile and high protein content.

Industry leaders are heavily investing in research and development to enhance product properties and employing sustainable and efficient extraction methods to boost product quality and yield.

Key Takeaways from the Market Report:

  • The global market value is estimated to total USD 10.6 billion by 2034.
  • Based on product type, the rapeseed protein isolated segment is set to advance at a CAGR of 2.8% through 2034.
  • By nature, the conventional rapeseed segment dominated the industry with a share of 62% in 2023.
  • China is predicted to record a CAGR of 3.8% between 2024 and 2034.
  • Sales in the United States are projected to total USD 1.9 billion by 2034.

Competitive Landscape

Key players in the rapeseed protein market are actively developing new protein products, including hydrolysates, concentrates, and isolates, to meet diverse industrial needs. Significant investments are being made by companies such as DSM in research and development to enhance the taste, texture, and functionality of rapeseed protein, aiming to increase its consumer appeal.

To drive sales growth and revenue, companies are forming strategic partnerships with food manufacturers and cosmetic brands. Additionally, the competitive landscape is intensifying due to strategies such as mergers, acquisitions, distribution agreements, and new facility expansions.

Efforts are also being made to educate consumers about the health and environmental benefits of rapeseed protein. These initiatives are expected to play a crucial role in expanding the customer base in the coming years.

Industry Updates

  • In January 2023, Poland-based NapiFeryn BioTech Sp. Zo.o., the developer of unique, patented technology for extracting rapeseed/canola protein from side streams of oil processing, closed a USD 2.5 million investment led by Icos Capital to launch the company’s canola protein from large oil processing side streams.
  • In April 2023, DSM, headquartered in Netherlands, announced the acquisition of the postbiotics company Adare Biome.

Leading Rapeseed Protein Brands

  • DSM
  • TEUTEXX
  • Europa Crown Ltd.
  • NapiFeryn BioTech
  • GP Feeds Ltd.
  • Others

Get Strategic Guidance from Our Analyst Contact us on: +1-347-918-3531

Key Segments of the Market Report

By Product Type:

Based on product type, the industry is segmented into isolates, concentrates, and hydrolysates.

By Nature:

When it comes to nature, the sector is categorized into conventional rapeseed and organic rapeseed.

By Application:

In terms of applications, the sector is segmented into food and beverages, animal feed, nutritional and dietary supplements, cosmetics and personal care products, and others. The food and beverages segment is further divided into bakery, confectionery products, meat, dairy, and others.

By Region:

Industry analysis has been carried out in key countries of North America, Latin America, Europe, East Asia, South Asia, Oceania, and the Middle East and Africa.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Fertility and Pregnancy Rapid Test Kit Market Set for Significant Growth, Projected to Reach USD 1,609.1 Million by 2033 at a 5% of CAGR

Fertility and Pregnancy Rapid Test Kit Market
Fertility and Pregnancy Rapid Test Kit Market

The global fertility and pregnancy rapid test kit market is on an upward trajectory, with a current valuation of USD 948.3 million in 2022. The market is anticipated to grow to USD 990.4 million by the end of 2023. Over the forecast period, the industry is expected to expand at a compound annual growth rate (CAGR) of 5%, reaching an estimated USD 1,609.1 million by 2033.

Due to shifts in healthcare choices and increased awareness worldwide, the market for fertility and pregnancy test kits is expanding gradually but steadily. These kits give consumers the privacy, simplicity of use, and clarity they need to make informed decisions about their reproductive health.

Key Takeaways from the Market Analysis

  • The fertility and pregnancy rapid test kit market developed at a 4% CAGR throughout the historical period.
  • The market in the United States is expected to increase at a 5.2% CAGR over the forecast period.
  • From 2023 to 2033, the fertility and pregnancy rapid test kit market in China is set to garner a 6% CAGR.
  • The market in France is expected to increase at a 4.2% CAGR from 2023 to 2033.
  • The fertility and pregnancy rapid test kit market in Japan is predicted to flourish at a 4.7% CAGR over the projected period.
  • The market in the United Kingdom is forecast to advance at a 4.9% CAGR over the projected period.
  • The pregnancy rapid test kit segment is anticipated to capture a CAGR of 4.5% through 2033.
  • The hCG urine test segment is predicted to secure a CAGR of 6.2% from 2023 to 2033.

“The availability of at-home self-test kits, successful early pregnancy detection, and the affordability of fertility and pregnancy rapid test kit are additional benefits contributing to the overall growth of the market,”- remarks an FMI analyst.

Competitive Landscape

Manufacturers are evolving their product portfolios of fertility and pregnancy rapid test kit by launching new products. This covers various test sensitivity levels, formats (e.g., blood, digital, urine-based), and packaging choices (e.g., single-use kits, multi-pack alternatives).

Manufacturers may increase revenue and sales by catering to various consumer requirements and tastes through a wide range of products.

Prominent players in the fertility and pregnancy rapid test kit market are

  • Alere Inc.
  • Quidel Corporation
  • Prestige Brands Holdings, Inc.
  • Church & Dwight Co., Inc.
  • bioMérieux SA
  • Geratherm Medical AG
  • Abbott Laboratories
  • Procter & Gamble Co.
  • DCC Plc.
  • Swiss Precision Diagnostics GmbH

Key Developments

  • In 2022, to help individuals throughout their whole reproductive journey, Kindbody launched the Kind at Home fertility kits, its consumer goods business. Their first offering is an easy-to-use at-home fertility hormone test for both men and women.

With the Kind at Home fertility test kit, customers may conveniently obtain detailed information regarding their fertility status from the comfort of their own homes. Kindbody physicians make individualized suggestions that can be brought to the online or in-person clinic consultation with the patients.

  • PregaScreen is a home pregnancy test kit that was introduced by Mylab Discovery Solutions. With this, the business has officially entered the female healthcare market. The kit is available for purchase over the counter at neighborhood pharmacies around the nation. It yields accurate findings in a matter of minutes. Pregnancy stick devices and droppers are included with every package.
  • In 2023, Proov and 2San, a reputable global leader in self-diagnostic testing, teamed to provide the unique, simple-to-use, at-home fertility tests of Proove in a few Midwest Hy-Vee locations. With its four products—Reserve (follicle stimulating hormone), Predict (luteinizing hormone), Confirm (PdG), and Check (human chorionic gonadotropin)—their range of tests provides a thorough evaluation of fertility at an affordable price.

Segmentation Analysis of the Fertility and Pregnancy Rapid Test Kit Market:

By Product:

  • Pregnancy Rapid Tests
    • Line Indicator devices
      • Strips/Dip Sticks
      • Mid-Stream
      • Cassettes
    • Digital
  • Fertility Rapid Tests
    • Line Indicator
    • Digital

By Test Type:

  • LH Urine
  • FSH Urine
  • hCG Blood
  • hCG Urine

By Distribution channel:

  • Pharmacy
  • Drugstore
  • Gynecology/Fertility Clinics
  • e-commerce
  • Hypermarkets & Supermarkets

By Region:

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • South Asia and Pacific
  • East Asia
  • The Middle East & Africa

Examine an Enlightening – Report

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Hemostat Market Projected to Grow at 5.8% CAGR from 2016 to 2025

Hemostat Market
Hemostat Market

The Indian hemostat market, valued at USD 54.1 million in 2015, is anticipated to experience significant growth over the next decade. The market is projected to expand at a robust Compound Annual Growth Rate (CAGR) of 5.8% from 2016 to 2025. This growth is driven by advancements in hemostat products and increasing adoption among medical practitioners and surgeons, fueled by a rise in surgeries and trauma cases across the country.

The surge in market growth is attributed to ongoing innovations in hemostat technology and the growing recognition of the critical role these products play in managing bleeding during medical procedures. As the number of surgeries and trauma cases continues to increase, the demand for effective hemostat solutions is expected to rise correspondingly.

However, India hemostat market is projected to register a healthy CAGR of 5.8% during the forecast period owing to factors such as benefits offered by these products and creating product image of hemostat among key opinion leaders such as healthcare professionals. Moreover, increasing number of accidents and trauma injuries is expected to drive growth of the India hemostat market during the forecast period. This report assesses trends driving growth of each segment in the market, and offers potential takeaways and strategic recommendations for manufacturers seeking to enter the market.

This report covers the India hemostat market and various segments in terms of revenue contribution. The report also includes FMI’s analysis of key trends, drivers, restraints and opportunities that are influencing growth of the India hemostat market. Impact analysis of key growth drivers and restraints is included in this report to better equip clients with crystal-clear decision-making insights.

The hemostat market is segmented based on product type, product material base, applications and distribution. Based on product type, the market has been segmented into mechanical product type and flowable product type. The mechanical type segment is expected to register a CAGR of 6.0% during the forecast period. Flowable type segment is expected to witness a decline in market share in terms of revenue from 11.7% in 2015 to 10.1% in 2025. Overpriced products is expected to affect demand for hemostat products over the forecast period.

Basically there are two product material base; gelatin base and oxidised cellulose base, gelatin base comprises of 77.0% market share of hemostat market in India owing to maximum usage of gelatin in all hemostat products as it has property of absorbing blood flow at a faster speed and healing the wound.

Furthermore hemostat products are segmented into application, surgeries and trauma cases. Surgery segment is expected to witness a decline in market share in terms of revenue from 63.7% in 2015 to 61.8% in 2025. The trauma cases segment is expected to expand at the highest CAGR of 6.3% over the forecast period.

The market has also been segmented by distribution channel into hospitals, ambulatory surgical centres, clinics and online channels. The hospitals segment followed by ambulatory surgical centres is expected to account for the highest demand for hemostat products over the forecast period, registering a CAGR of 7.0% and 5.7%.

Due to reimbursement for surgeries by insurance payers and increased in adoption of hemostat products by medical practitioners and surgeons. To reach out to the consumers and healthcare professionals manufacturers are supplying products through E-Commerce which is expected to push demand for hemostat products in the online channel over the forecast period.

Furthermore, Future Market Insights has developed market attractiveness index for all four segments: product type, product base, application and distribution channel segments. This index helps in identifying the real opportunities in the market.

Key market players covered in this report

Johnson and Johnson (Ethicon), Baxter, Aegis Lifesciences, Eucare Pharmaceuticals and Mil Laboratories. Major players are focusing on enhancing their regional presence through strategic mergers & acquisitions and by expanding operations.

A Full Report – Overview

Key Segments Covered

Segmentation on basis of Product Type

  • Mechanical type
  • Flowable type

Segmentation on basis of Product Material Base

  • Gelatin
  • Oxidized cellulose

Segmentation on basis of Application

  • Surgery
  • Trauma cases

Segmentation on basis of Distribution Channel

  • Hospitals
  • Ambulatory Surgical Centers
  • Clinics
  • Online Channels

Segmentation on basis of Geography
India

 About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:      

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Electronic Medical Record Market Set for Robust Growth, Projected to Reach USD 34.34 Billion by 2034 at a 6.20% of CAGR

Electronic Medical Records Market
Electronic Medical Records Market

Future Market Insights’ latest report on the electronic medical record (EMR) ecosystem underscores the significant opportunities and growth prospects anticipated over the next decade. The report reveals that the EMR market is currently valued at USD 18.82 billion in 2024 and is expected to expand substantially, reaching an estimated USD 34.34 billion by 2034. This growth represents a robust compound annual growth rate (CAGR) of 6.20% throughout the forecast period.

The report underscores the continuous demand for electronic medical records, driven by the industry’s focus on simplifying user interfaces and improving the clarity of information. As electronic medical record producers align their offerings with consumers’ needs for more intuitive and understandable systems, the demand for EMR solutions is expected to rise substantially.

This remarkable expansion underscores the escalating adoption of electronic medical records (EMR) across the healthcare landscape, revolutionizing the way patient information is documented, managed, and utilized.

As the healthcare industry seeks scalable solutions to meet evolving demands, numerous healthcare providers are opting for electronic health records as a software-as-a-service (SaaS) model. This approach ensures seamless integration, improved data accessibility, and greater operational efficiency, contributing to the market’s overall momentum.

The future of healthcare is being reshaped by EMR systems, providing comprehensive, secure, and accessible patient data management. As the industry continues to evolve, the global EMR market is poised to play a pivotal role in enhancing healthcare delivery and

The market is expanding as a result of an increase in the number of benefits, including lower infrastructure and maintenance expenses, lower license and start-up costs, and greater accessibility. Improved productivity and quicker, simpler adoption are two benefits of cloud-based EMR solutions. The application is incredibly scalable because of its cloud-based architecture (pay-as-you-go storage utilization). It removes departmental silos of healthcare data to streamline and consolidate storage resources to reduce costs and boost efficiency.

Large, well-known firms are starting to enter the cloud sector. To maintain the level of patient care, the cloud infrastructure also provides real solutions for business continuity and disaster recovery. As a result, it is anticipated that the market for cloud-based EMR will expand dramatically. To give medical staff relatively easy access to patient records, the digital revolution in healthcare is essential. During the projection period, it is predicted that the growing need for systems and software that connect hospitals, clinics, and other healthcare facilities will become a growth driver.

A greater emphasis is placed on strategic partnerships between leading suppliers of electronic medical record solutions as market rivalry intensifies. Additionally, it is projected that the constantly growing need for knowledge sharing and technology upgrades to improve healthcare efficiency will foster partnerships between important actors.

Key Takeaways from the Electronic Medical Records Market

  • The US electronic medical records (EMR) market is anticipated to expand at a CAGR of 6% over the forecasted period.
  • By 2033, it is anticipated that the cost of implementing electronic medical records (EMR) in the US will surpass US$ 18.4 Bn.
  • The UK electronic medical records (EMR) industry is anticipated to expand at a CAGR of 8.4% throughout the anticipated time frame.
  • By 2033, the UK’s sales of electronic medical records (EMR) systems are anticipated to surpass US$ 1.6 billion.
  • The market for electronic medical records (EMR) in India is anticipated to expand at a CAGR of 8.2% over the forecasted period.
  • By 2033, the Indian market for electronic medical records (EMR) will reach more than US$ 255.0 Mn.
  • In 2021, the market for electronic medical records (EMR) was dominated by cloud-based EMRs, which accounted for more than 50.0% of total revenue.
  • Hospital electronic medical records (EMR) are expected to increase at a CAGR of 6.4% throughout the forecast period due to rising pandemic and epidemic infections and the requirement for global vaccination against a wide range of diseases.

Who is Winning?

According to Future Market Insights (FMI), top EMR solution providers are building alliances with the local healthcare system, engaging in mergers and acquisitions, and bolstering their distribution networks to develop and explore the underdeveloped markets of Asia and Latin America. To break into middle-income and emerging markets, market companies are also concentrating on raising awareness, lowering the price of EMR software and related services, and fusing EMR with contemporary technologies.

Microsoft Corp. acquired Nuance Communications, Inc. in April 2021 to empower healthcare providers with the power of ambient clinical intelligence and other Microsoft cloud services.
Capital Health, a regional leader in providing cutting-edge, high-quality patient care, introduced a new electronic health record (EGR) in the acute care divisions of both of its hospitals in February 2021 to better serve its patients.
The “Patient” database personal health record (PHR) of the patient will now be able to safely transfer the patient’s existing health records from the “Patient” database onto the Apple Health app, according to a May 2021 announcement from DrChrono. This should simplify the procedure and make it easier to access medical data more quickly.

A Full Report – Overview

Key Segments Covered in Electronic Medical Records Market Study

By Product Type:

  • Hospital EMR
  • Ambulatory EMR

By Component:

  • EMR Software
  • EMR Services

By Application:

  • Client Server Setup EMR
  • Hybrid Server Setup EMR
  • Cloud Based EMR

By End User:

  • Hospitals
  • Specialized Clinics
  • General Physician Clinics
  • Ambulatory Surgical Centers

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:      

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Gestational High Blood Pressure: Reasons, Signs, as well as Therapy

Gestational hypertension, additionally referred to as pregnancy-induced hypertension (PIH), is a condition that influences expecting ladies and also is defined by hypertension. It normally develops after the 20th week of pregnancy as well as, if left neglected, can fumarex farmacia del ahorro bring about severe difficulties for both the mom and also the infant. In this write-up, we will discover the causes, symptoms, and therapy alternatives for gestational hypertension.

Causes of Gestational Hypertension

The specific cause of gestational high blood pressure is not totally understood. Nevertheless, there are numerous variables that may add to its growth. These include:

  • Age: Advanced mother’s age, normally over 35 years of ages, boosts the risk of creating gestational high blood pressure.
  • Weight problems: Females that are obese or overweight before maternity are most likely to experience gestational high blood pressure.
  • Existing medical problems: Females with pre-existing problems such as persistent hypertension, diabetes, kidney condition, or autoimmune problems are at a greater danger.
  • First maternity: First-time moms have a slightly higher risk of developing gestational high blood pressure compared to ladies who have actually had previous maternities.
  • Several maternities: Women lugging doubles, triplets, or even more have actually an enhanced probability of creating gestational hypertension.

Signs And Symptoms of Gestational High Blood Pressure

Gestational hypertension typically does absent any kind of obvious signs and symptoms. Nevertheless, some women may experience the following:

  • Hypertension readings throughout prenatal visits
  • Swelling of the hands, feet, or face
  • Protein in the urine
  • Extreme frustrations
  • Blurred vision or various other modifications in vision
  • Stomach discomfort
  • Shortness of breath

If you experience any one of these signs and symptoms, it is very important to consult your healthcare provider for an appropriate medical diagnosis and also suitable therapy.

Problems of Gestational Hypertension

Unattended gestational high blood pressure can bring about a number of difficulties, including:

  • Preeclampsia: This is an extreme type of gestational hypertension that can cause damage to organs and also affect the placenta, bring about bad fetal development and also development.
  • Preterm birth: Gestational hypertension raises the danger of delivering the baby prematurely, which can bring about numerous health problems for the infant.
  • Placental abruption: This happens when the placenta separates from the uterine wall surface prematurely, which can create hefty bleeding and damage the baby.
  • Reduced birth weight: Infants born to mothers with gestational hypertension may have a lower birth weight than average.

It is critical to keep an eye on and manage gestational high blood pressure to reduce the risks to both mother and child.

Therapy options for Gestational High blood pressure

The main objective of dealing with gestational high blood pressure is to keep a steady blood pressure and also lessen the danger of complications. Treatment choices may consist of:

  • Way of life modifications: Making healthy and balanced modifications to your diet regimen, working out on a regular basis, handling tension, and obtaining enough rest can assist manage high blood pressure levels.
  • Medicine: In some cases, your healthcare provider might suggest antihypertensive medications to lower your high blood pressure.
  • Regular monitoring: Routine prenatal check-ups and high blood pressure measurements are essential to track the progress of gestational high blood pressure.
  • Induction of labor: If gestational high blood pressure comes to be severe or if preeclampsia establishes, your doctor might recommend causing labor to secure the health of both you as well as your child.

It is essential to follow your healthcare provider’s advice and also participate in all scheduled appointments to ensure the most effective feasible result for you and also your infant.

Verdict

Gestational hypertension is a problem that impacts expecting ladies and is characterized by hypertension. It is essential to be knowledgeable about the prospective reasons, signs, as well as treatment options for this problem to ensure very early discovery as well as appropriate management. By working closely with your doctor and also adopting a healthy and balanced lifestyle, you can effectively manage gestational hypertension and also promote a healthy and balanced pregnancy.

What Is Driving the Growth of the Hair Bond Multiplier Market from 2023 to 2033?

With increasing emphasis on self-care and growing awareness of personal grooming, the hair bond multiplier market is projected to reach a global revenue of US$ 330 million by 2033. In 2023, the market value stands at US$ 191.5 million, and it is anticipated to experience a steady growth rate of 5.6% throughout the forecast period from 2023 to 2033.

The hair bond multiplier market has emerged as a significant player in the beauty and hair care industry, revolutionizing the way consumers repair and strengthen damaged hair. Between 2023 and 2033, the market is projected to witness substantial growth, driven by increasing consumer awareness of hair care solutions, product innovations, and the rising demand for salon-quality treatments at home. This blog provides an in-depth analysis of the market, focusing on historical sales data, current demand outlook, key growth drivers, and the factors hindering growth. Additionally, recent developments within the industry are highlighted.

Historical Sales Analysis (2018-2022) vs. Demand Outlook (2023-2033)

Historically, the hair bond multiplier market gained momentum in the late 2010s with the launch of innovative products that repair broken bonds in hair, notably in response to damage from chemical treatments such as bleaching, coloring, and heat styling. The period from 2018 to 2022 saw steady growth, driven primarily by the increasing adoption of these products by professional hairstylists and salon chains. Consumer demand for effective home hair repair solutions also surged, particularly during the COVID-19 pandemic when salons were temporarily closed.

From 2023 to 2033, the demand for hair bond multipliers is expected to rise significantly, driven by the growing popularity of clean beauty and sustainable hair care products. Consumers are becoming more aware of the need to maintain the health of their hair, especially as they experiment more with different hair colors and treatments. Brands are capitalizing on this trend by expanding their product offerings, developing vegan, cruelty-free, and chemical-free formulas, and marketing to a broader demographic, including men.

Factors Restraining the Hair Bond Multiplier Market

While the hair bond multiplier market is on an upward trajectory, there are a few factors that could restrain its growth.

  1. High Cost of Premium Products: Hair bond multipliers are typically priced at a premium compared to regular hair care products. This makes them less accessible to budget-conscious consumers, especially in regions where disposable income is lower. While professional salon treatments justify their price, at-home treatments can be seen as a luxury for some consumers.
  2. Limited Consumer Awareness: Despite the growing popularity, there remains a segment of the population that is unaware of the benefits of hair bond multipliers. Many consumers are still reliant on traditional hair care products like conditioners and serums, without understanding how bond multipliers offer deeper, more structural repair for damaged hair. Overcoming this lack of awareness is crucial to expanding the market.
  3. Potential for Product Misuse: Hair bond multipliers are scientifically formulated products that need to be used as directed for optimal results. Incorrect application or overuse can lead to less-than-desirable outcomes, which can deter repeat purchases and damage the brand’s reputation. Ensuring that consumers understand how to properly use these products is important for brand loyalty.
  4. Competition from Alternative Hair Treatments: Other hair repair products, such as keratin treatments, protein masks, and deep conditioners, still hold a strong market share. Consumers may opt for these alternatives, particularly if they are looking for a more budget-friendly or accessible option. Brand differentiation is key to standing out in a crowded market.

Recent Developments in the Hair Bond Multiplier Market

Innovation is at the heart of the hair bond multiplier market, with brands continuously pushing the envelope in terms of formulation, delivery, and product accessibility. Some of the recent developments include:

  1. Introduction of Clean Beauty Hair Bond Multipliers: Consumers are increasingly seeking products that align with their eco-conscious values. This has led to the rise of clean beauty hair bond multipliers, which are free from harmful chemicals like parabens, sulfates, and synthetic fragrances. Brands are also focusing on using biodegradable packaging and sustainable sourcing practices to appeal to eco-conscious consumers.
  2. Expansion of Men’s Hair Care Segment: Traditionally, hair bond multipliers have been marketed toward women, but brands are now expanding their product lines to include men’s hair care. Men are becoming more invested in maintaining healthy hair, particularly as trends like hair coloring and styling gain popularity. Offering products tailored to men’s needs is likely to boost market demand.
  3. Technological Advancements: Research and development in the hair care industry have led to the creation of more advanced hair bond multiplier formulations. These newer versions promise quicker results, better damage protection, and longer-lasting effects. Additionally, brands are developing products that target specific hair types, making them more personalized and effective.
  4. Collaborations with Professional Salons: Many brands are leveraging partnerships with professional hairstylists and salons to increase product visibility and trust among consumers. By offering exclusive salon treatments and at-home kits, brands are providing a comprehensive solution that bridges the gap between professional and consumer-grade products.

Market segmentation

By Product Type:

  • Kit
  • Loose

By Application:

  • Hair Colouring
  • Hair Treatment

By End Use:

  • Salons
  • Spa
  • Personal Use

By Distribution Channel:

  • Direct Sales
  • Retail Sales
  • Modern Trade Distributors and Wholesalers
  • Health & Beauty Stores
  • Online Retailers

By Region:

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East and Africa

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact FMI:   

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

 

Market Growth for Elecampane Root: Forecasting a 5.4% CAGR Through 2033

The global Elecampane Root market is projected to attain a valuation of USD 851 million by 2023, with an expected compound annual growth rate (CAGR) of 5.4% from 2023 to 2033. By 2033, the market is anticipated to reach USD 1,440 million.

Elecampane, a herb native to parts of Europe and Asia, is used to produce elecampane root. This root is also cultivated in various regions of North America. In medicine, elecampane root is primarily utilized for treating respiratory conditions such as asthma, bronchitis, and whooping cough, among others. Despite its demonstrated therapeutic benefits in numerous studies, the medical board has not officially approved its use. Consequently, elecampane root is available over the counter without a prescription.

Elecampane root is typically available in dried form, either as whole roots or powdered. It is also sold in various dietary supplements, such as pills and tinctures. The price of elecampane root can vary based on its form and the retailer, but it is generally considered to be affordable.

The market for elecampane root has been experiencing gradual growth, driven by the increasing popularity of herbal and natural remedies. As more individuals seek natural alternatives to conventional medicine, this trend is expected to persist. The market for elecampane root is forecasted to continue expanding, fueled by growing consumer awareness of its health benefits. Additionally, the rising demand for natural and organic products is anticipated to further boost the market for elecampane root and other traditional medicinal herbs.

Although elecampane root has been used medicinally for centuries, its benefits have only recently gained widespread attention. As research into its properties advances, elecampane root is being incorporated into a broader array of products. Despite its traditional use, elecampane root is not widely cultivated. To meet the growing demand, there has been an increase in elecampane root farming in North America. Once the medical board grants official approval, demand for elecampane root is expected to expand significantly.

Competitive Landscape

The Elecampane Root market is relatively consolidated, with major players focusing on growth strategies such as mergers, acquisitions, and expanding their distribution networks to strengthen their market presence. Competitors in the market employ various tactics, including launching new products, promoting free-from claims, and emphasizing organic and natural origins to differentiate themselves.

Key Companies Profiled

Mountain Rose Inc.

Napiers Herbals Ltd.

Monterey Bay Spice Company

Starwest Botanicals Inc.

Organic Herb Trading Co.

Furnace Creek Farm

Get Connected with Our Expert Analyst on Email: sales@futuremarketinsights.com

Elecampane Root Market by Category

By Nature:

  • Organic
  • Conventional

By Form:

  • Cut-Form
  • Powdered
  • Liquid

By End Use:

  • Beverages
  • Non-Alcoholic
  • Alcoholic
  • Foodservice/ HoReCa (Hotels, Restaurants, Cafes)
  • Pharmaceuticals
  • Nutraceuticals
  • Animal Supplement
  • Personal Care & Cosmetics
  • Household/Retail

By Distribution Channel:

  • B2B/ Direct
  • B2C/ Indirect
  • Supermarket/ Hypermarket
  • Specialty Stores
  • Drug Stores
  • Online Retailers

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East & Africa

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Cream of Tartar Industry Growth: CAGR of 6.0% Expected to Drive Market Value to USD 437 Million by 2033

According to a study by Future Market Insights, the Cream of Tartar market is projected to grow at a compound annual growth rate (CAGR) of 6.0% throughout the forecast period. The market value is expected to rise from USD 244.0 million in 2023 to USD 437.0 million by 2033. At the end of 2022, the market was valued at USD 231.3 million.

Cream of tartar, an acidic salt originally discovered by the French, is derived from residues left in barrels after processing wine and grape juice. It is commonly used as a stabilizing agent when whipping egg whites, enhancing their volume while preserving their whiteness and brightness for extended periods.

Between 2018 and 2022, the global Cream of Tartar market grew from USD 186.7 million to USD 231.3 million, reflecting a compound annual growth rate (CAGR) of 5.5%.

The expansion of the food and fast food industries has been a key driver of this growth, fueled by rising consumer demand for baked goods. A significant factor in the market’s development is the lack of a direct substitute for Cream of Tartar.

While alternatives like vinegar and lemon juice can be used, they often require larger quantities to mimic the effects of Cream of Tartar, which can alter the original recipes and limit their effectiveness.

Competitive Landscape

As the market for cream of tartar continues to grow, it’s important to understand the competitive landscape. Cream of tartar is a versatile ingredient used in a variety of food and beverage applications, so it’s no surprise that a number of companies are competing for a share of the market. Here we take a look at some of the key players in the cream of tartar market, and we explore the strategies they’re using to stay ahead of the competition.

Key Companies Profiled

McCormick & Company Inc

Tártaros Gonzalo Castello SL

ATP Group, Newseed Chemical Co. Limited

A&K Petrochem Industries Limited

Foodchem International Corporation

Shanghai AiBo Additive Co. Ltd.

SIP Chemical Industries

GC Chemicals Corporation

American Elements

Get Strategic Guidance from Our Analyst Contact us on: +1-347-918-3531

Cream of Tartar Market by Category

By Application, Cream of Tartar Market is segmented as:

  • Chemical
  • Household
  • Pharmaceutical

By Sales Channel, Cream of Tartar Market is segmented as:

  • Modern Trade
  • Departmental and Traditional Grocery Store
  • Convenience Stores
  • Online Channels
  • Other Retail Formats

By Region, Cream of Tartar Market is segmented as:

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Oceania
  • MEA

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Light Therapy Market Poised for Growth, Projected to Reach USD 1,586.8 Million by 2034 at a 4.6% of CAGR

Light Therapy Market
Light Therapy Market

The global light therapy market is set for significant expansion, with projections indicating a rise from USD 1,017.2 million in 2023 to USD 1,586.8 million by 2034. The market is anticipated to grow at a steady compound annual growth rate (CAGR) of 4.6% throughout the forecast period.

Key Takeaways:

  • Current Market Value: The light therapy market was valued at USD 1,017.2 million in 2023.
  • Forecasted Growth: The market is expected to reach USD 1,012.1 million in 2024 and expand to USD 1,586.8 million by 2034.
  • Growth Rate: The market is anticipated to grow at a CAGR of 4.6% over the forecast period.
  • Market Drivers: Increasing awareness of light therapy’s benefits, advancements in technology, and the rising prevalence of conditions such as seasonal affective disorder (SAD) are driving market growth.

This promising outlook for the light therapy market reflects its growing adoption as a therapeutic solution for various health conditions, supported by ongoing advancements in the field.

In 2023, the light therapy market was valued at USD 1,017.2 million, demonstrating its established presence and continued expansion within the therapeutic landscape. Light therapy, also known as phototherapy, has gained recognition for its efficacy in treating various conditions, including mood disorders, sleep disorders, and skin conditions.

Recent studies highlight the benefits of light therapy in managing seasonal affective disorder (SAD), depression, and sleep problems, reinforcing its therapeutic value. The increasing awareness and adoption of light therapy for these applications are contributing to the market’s robust growth.

There has been a notable increase in the prevalence of both insomnia and personal depression in recent years. Apart from depression and insomnia, light therapy has gained popularity due to disturbed sleep patterns. Due to these circumstances, sales of progressive treatment equipment—which uses superior UV light to treat various disorders—have increased significantly.

Competition Analysis of the Light Therapy Market

The market for light therapy is competitive, with large companies tussling it out with smaller players for a piece of the pie. Startups are flourishing in the light therapy landscape.  Some of the prominent companies in the market include Koninklijke Philips N.V., Verilux Inc., Northern Light Technology, and Sphere Gadget Technologies.

Recent Developments in the Light Therapy Market

  • In August 2023, Eyerising International Pty Ltd.’s myopia management device, which uses red light therapy, received approval from the Australian Therapeutic Goods Administration (TGA).
  • In February 2022, a partnership was announced between Arizona Coyotes and Mito Red Light Inc.

Key Companies in the Light Therapy Market:

  • Koninklijke Philips N.V.
  • Verilux Inc.
  • Northern Light Technology
  • Sphere Gadget Technologies
  • Zepter International
  • PhotoMedex Inc.
  • Luminette
  • Klarstein
  • Lumie
  • Aura Daylight
  • Lifepro Fitness
  • STRATA Skin Sciences, Inc.
  • Oralucent
  • Mito Red Light Inc.

A Full Report – Overview

Key Segments

By Product:

  • Light Box
  • Floor and Desk Lamps
  • Light Visor
  • Dawn Simulator
  • Light Therapy Bulbs

By Light Type:

  • White Light
  • Red Light
  • Blue Light

By End User:

  • Dermatology Clinics
  • Homecare Settings
  • Others (Workplace, Salons)

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa (MEA)

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube